128 related articles for article (PubMed ID: 3860291)
1. Paradoxical effect of BW 301U, a lipophilic antifolate, on methotrexate-inhibitable deoxyuridine incorporation by human hematopoietic cells.
Iland HJ; Laszlo J; Sedwick WD
Cancer Res; 1985 Aug; 45(8):3962-8. PubMed ID: 3860291
[TBL] [Abstract][Full Text] [Related]
2. Overcoming methotrexate resistance by a lipophilic antifolate (BW 301U): from theory to models to practice.
Laszlo J; Iland HJ; Sedwick WD
Adv Enzyme Regul; 1985; 24():357-75. PubMed ID: 3915188
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase.
Duch DS; Edelstein MP; Bowers SW; Nichol CA
Cancer Res; 1982 Oct; 42(10):3987-94. PubMed ID: 6955006
[TBL] [Abstract][Full Text] [Related]
4. Effect of trimethoprim on folate-dependent DNA synthesis in human bone marrow.
Sive J; Green R; Metz J
J Clin Pathol; 1972 Mar; 25(3):194-7. PubMed ID: 5018713
[TBL] [Abstract][Full Text] [Related]
5. Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301U.
Klohs WD; Steinkampf RW; Besserer JA; Fry DW
Cancer Lett; 1986 Jun; 31(3):253-60. PubMed ID: 2941142
[TBL] [Abstract][Full Text] [Related]
6. Synchronization and recruitment in acute leukemia.
Lampkin BC; Nagao T; Mauer AM
J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow.
Waxman S; Herbert V
N Engl J Med; 1969 Jun; 280(24):1316-9. PubMed ID: 5771778
[No Abstract] [Full Text] [Related]
8. Effect of nitrous oxide on human bone marrow cells and its synergistic effect with methionine and methotrexate on functional folate deficiency.
Kano Y; Sakamoto S; Sakuraya K; Kubota T; Hida K; Suda K; Takaku F
Cancer Res; 1981 Nov; 41(11 Pt 1):4698-701. PubMed ID: 7306986
[TBL] [Abstract][Full Text] [Related]
9. Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-Diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies.
Huang YL; Lin CF; Lee YJ; Li WW; Chao TC; Bacherikov VA; Chen KT; Chen CM; Su TL
Bioorg Med Chem; 2003 Jan; 11(1):145-57. PubMed ID: 12467717
[TBL] [Abstract][Full Text] [Related]
10. Biochemical pharmacology of lipophilic diaminopyrimidine antifolates in mouse and human cells in vitro.
Greco WR; Hakala MT
Mol Pharmacol; 1980 Nov; 18(3):521-8. PubMed ID: 6970329
[No Abstract] [Full Text] [Related]
11. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
Sedwick WD; Kutler M; Frazer T; Brown OE; Laszlo J
Cancer Res; 1979 Sep; 39(9):3612-8. PubMed ID: 314333
[TBL] [Abstract][Full Text] [Related]
12. Deoxyuridine metabolism in human megaloblastic marrow cells.
Van Der Weyden MB
Scand J Haematol; 1979 Jul; 23(1):37-42. PubMed ID: 493870
[TBL] [Abstract][Full Text] [Related]
13. Effect of methotrexate on the deoxyuridine suppression test: results with different cell preparations.
Kanazawa S; Iwasa S; Iseki T; Okuda K; Kondo H; Okuda K
Am J Hematol; 1988 Feb; 27(2):89-92. PubMed ID: 3341372
[TBL] [Abstract][Full Text] [Related]
14. Relative biochemical aspects of low and high doses of methotrexate in mice.
Zaharko DS; Fung WP; Yang KH
Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
[TBL] [Abstract][Full Text] [Related]
15. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of X-methyl folate preparations as possible folic acid antagonists.
Waxman S; Schreiber C; Waxman S
Chemotherapy; 1982; 28(5):402-9. PubMed ID: 7140422
[TBL] [Abstract][Full Text] [Related]
17. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
18. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
Chabner BA; Young RC
J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
[TBL] [Abstract][Full Text] [Related]
19. Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
Taylor IW; Slowiaczek P; Friedlander ML; Tattersall MH
Cancer Res; 1985 Mar; 45(3):978-82. PubMed ID: 3971388
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C
J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
